Amiodarone Prophylaxis: Impact on Atrial Fibrillation and Outcomes after Cardiac Surgery

This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly...

Full description

Saved in:
Bibliographic Details
Published in:Hospital pharmacy (Philadelphia) 2007-08, Vol.42 (8), p.680-685
Main Authors: Howard, Patricia A., Barnes, Brian J.
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This continuing feature will update readers on recent developments in cardiovascular pharmacotherapy. Cardiovascular disease remains the number one killer in the United States, and more clinical outcome trials have been conducted in cardiology than in any other field of medicine. Given this rapidly expanding knowledge base, pharmacists can have a significant impact on prevention and treatment—if they keep current with developments in drug therapy.
ISSN:0018-5787
1945-1253
DOI:10.1310/hpj4208-680